Registration is open for the inaugural Atopic Dermatitis (AD) Summit. The virtual symposium will be held on Saturday, April 23, 2022, at 10:00 a.m. EDT.
Internalized skin bias negatively impacts QoL of HS patients
A new study has shown that internalized skin bias negatively impacts the mental health and quality of life (QoL) of patients with hidradenitis suppurativa (HS).
New study shows 1,064 nm lasers most effective for tattoo removal
A pre-clinical comparative study has shown that 1,064 nm lasers may be most effective in tattoo removal.
Difamilast ointment shows efficacy in treating atopic dermatitis
A new study found difamilast ointment 1% to be safe and efficacious in the treatment of atopic dermatitis (AD).
Psoriasis patients with and without psoriatic arthritis self-report higher analgesic use
According to a new study, psoriasis patients, with and without psoriatic arthritis (PsA), self-report using analgesics more than those without the disease. This may be due to increased joint pain.
Ustekinumab less effective for psoriasis in lower extremities, according to study
A new study has shown that clinical response in psoriasis patients treated with ustekinumab tends to vary by anatomical region, with the lower extremities seeing the least response.
Dupilumab-induced ocular surface disease more frequently associated with AD, study shows
According to a new study, dupilumab-induced ocular surface disease (DIOSD) appears to occur more frequently in patients with atopic dermatitis (AD) than in patients with other conditions being treated with the biologic.
University of Toronto establishes Chair in Ethnodermatology position
The University of Toronto has just established the AbbVie Chair in Ethnodermatology, one of the first positions of its kind, to support diversity in dermatology training, research and care, according to a press release.
Study shows early response to biologics linked to stable long-term efficacy in psoriasis
Findings from a new study has shown that early response to ixekizumab and ustekinumab is associated with maintaining stable long-term skin clearance in patients with moderate-to-severe psoriasis.
Self-help interventions help reduce shame and improve QOL in psoriasis patients, study shows
According to a new study, some psoriasis patients may experience a reduction in shame and improvement in quality of life (QOL) after exposure to self-help interventions.
HealthMinute.TV 